On September 2, 2022, Genome & Company closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9,640 KRW | +15.73% |
|
+15.73% | -22.82% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
13,910 KRW | +0.07% | +0.22% | 8B | ||
7,860 KRW | +0.26% | +3.15% | 2.92B | ||
1st Jan change | Capi. | |
---|---|---|
-22.82% | 91.92M | |
+24.74% | 47.96B | |
-0.47% | 42.45B | |
+43.96% | 41.47B | |
+25.40% | 31.6B | |
+17.96% | 28.63B | |
-4.47% | 28.03B | |
+50.73% | 14.56B | |
+42.56% | 14.14B | |
+1.46% | 12.58B |
- Stock Market
- Equities
- A314130 Stock
- News Genome & Company
- Genome & Company announced that it has received KRW 34.34975035 billion in funding from a group of investors